Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor × Tegafur × Clear all

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Stomach Neoplasms 19 Colorectal Neoplasms 7 Colonic Neoplasms 7 Rectal Neoplasms 6 Carcinoma, Hepatocellular 6 Pancreatic Neoplasms 5 Esophageal Squamous Cell Carcinoma 4 Unspecified Adult Solid Tumor, Protocol Specific 3 Squamous Cell Carcinoma of Head and Neck 3 Breast Neoplasms 3 Biliary Tract Neoplasms 3 Head and Neck Neoplasms 2 HER2-positive Gastric Cancer 2 Gallbladder Neoplasms 2 Esophageal Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Stage IA Pancreatic Adenocarcinoma 1 Solid Tumor 1 Recurrence 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1 Malignant Neoplasms of Digestive Organs 1 Lung Neoplasms 1 Klatskin Tumor 1 Fruquintinib 1 Extrapancreatic Neuroendocrine Tumor 1 Epstein-Barr Virus Infections 1 Efficacy and Safety 1

Interventions

pembrolizumab 11 Injections 11 Paclitaxel 10 Docetaxel 9 Cisplatin 8 Capecitabine 8 Nivolumab 7 Fluorodeoxyglucose F18 7 Bevacizumab 7 toripalimab 6 senaparib 6 atezolizumab 6 Irinotecan 6 Fluorouracil 6 tislelizumab 5 Cyclophosphamide 5 apatinib 4 Leucovorin 4 Ipilimumab 4 Gemcitabine 4 spartalizumab 3 pertuzumab 3 olaparib 3 fludarabine 3 camrelizumab 3 Rifampin 3 Radiosurgery 3 Oxaliplatin 3 Midazolam 3 Itraconazole 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04260269 2024-12-12

CardioSwitch

Helsinki University Central Hospital

Enrolling by invitation

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡